Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03142893 · ClinicalTrials.gov registry record · Phase 1

Hormonal Mechanisms of Sleep Restriction - Axis Study

A Phase 1 study of Sleep Restriction, sponsored by Peter y. Liu.

Active
Registry status
Phase 1
Development phase
80
Enrollment target
1
Study location

NCT03142893 is a Phase 1 study of Sleep Restriction that is active but no longer recruiting, run by Peter y. Liu. The registered enrollment target is 80 participants, above the 47-participant average among 4 other Sleep Restriction trials with a reported enrollment target (70% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03142893, a Phase 1 study of Sleep Restriction, is active but no longer recruiting, sponsored by Peter y. Liu.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to 1) determine how hypothalamic-pituitary-adrenal axis (HPA axis) activation occurs with sleep restriction 2) evaluate how hypothalamic-pituitary-gonadal axis (HPG axis) deactivation occurs with sleep restriction. The investigator will also examine the cognitive function associated with sleep restriction, including food intake and food cravings.

Conditions Studied

Interventions

  • DRUG Dexamethasone
  • DRUG Ketoconazole Pill
  • DRUG Ganirelix
  • DRUG Dexamethasone Injection
  • DRUG Cosyntropin Injectable Product

Study Locations (1)

California

  • Los Angeles Biomedical Research Institute - Torrance

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2017-05-08
Est. Completion 2026-06-30
Phase Phase 1

Sponsor

Peter y. Liu

1 total trials

What the Registry Record Tells You About NCT03142893

The ClinicalTrials.gov registry entry for NCT03142893 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 47-participant average among 4 other Sleep Restriction trials with a reported enrollment target (70% higher). The listed sponsor is Peter y. Liu, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sleep Restriction appearing as the primary indexed condition, and to 5 interventions - of which Dexamethasone is the first listed.

NCT03142893 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03142893 about?

NCT03142893 is a clinical study titled "Hormonal Mechanisms of Sleep Restriction - Axis Study". The purpose of this study is to 1) determine how hypothalamic-pituitary-adrenal axis (HPA axis) activation occurs with sleep restriction 2) evaluate how hypothalamic-pituitary-gonadal axis (HPG axis) deactivation occurs with sleep restriction. The investigator will also examine the cognitive functio...

What is the current status of trial NCT03142893?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2017-05-08. Estimated completion is 2026-06-30.

What conditions does trial NCT03142893 study?

This clinical trial studies the following conditions: Sleep Restriction.

What interventions are being tested in trial NCT03142893?

The interventions under investigation include: Dexamethasone (DRUG), Ketoconazole Pill (DRUG), Ganirelix (DRUG), Dexamethasone Injection (DRUG), Cosyntropin Injectable Product (DRUG).

Who is sponsoring clinical trial NCT03142893?

This trial is sponsored by Peter y. Liu, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03142893 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Restriction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.